Eli Lilly, Novo Nordisk rebuked by FDA for claims made in Oprah weight loss video

The U.S. FDA has issued separate warning letters to Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) regarding claims made about their obesity drugs in an Oprah Winfrey video special. The video, "An Oprah Special: Shame, Blame, and the Weight Loss Revolution," mentioned Lilly's Zepbound and ...